nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—migraine—Prednisone—hematologic cancer	0.624	1	CpDpCtD
Cyproheptadine—Ketotifen—PDE4B—hematologic cancer	0.000822	0.471	CrCbGaD
Cyproheptadine—Clozapine—H1F0—hematologic cancer	0.000468	0.268	CrCbGaD
Cyproheptadine—Protriptyline—ABCB1—hematologic cancer	0.000169	0.0969	CrCbGaD
Cyproheptadine—Diarrhoea—Irinotecan—hematologic cancer	8.38e-05	0.000308	CcSEcCtD
Cyproheptadine—Vomiting—Carmustine—hematologic cancer	8.38e-05	0.000308	CcSEcCtD
Cyproheptadine—Insomnia—Triamcinolone—hematologic cancer	8.36e-05	0.000308	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—hematologic cancer	8.36e-05	0.000308	CcSEcCtD
Cyproheptadine—Dizziness—Vincristine—hematologic cancer	8.32e-05	0.000306	CcSEcCtD
Cyproheptadine—Rash—Carmustine—hematologic cancer	8.31e-05	0.000306	CcSEcCtD
Cyproheptadine—Dermatitis—Carmustine—hematologic cancer	8.3e-05	0.000305	CcSEcCtD
Cyproheptadine—Vomiting—Alitretinoin—hematologic cancer	8.3e-05	0.000305	CcSEcCtD
Cyproheptadine—Paraesthesia—Triamcinolone—hematologic cancer	8.3e-05	0.000305	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—hematologic cancer	8.29e-05	0.000305	CcSEcCtD
Cyproheptadine—Feeling abnormal—Prednisolone—hematologic cancer	8.28e-05	0.000305	CcSEcCtD
Cyproheptadine—Headache—Carmustine—hematologic cancer	8.26e-05	0.000304	CcSEcCtD
Cyproheptadine—Shock—Betamethasone—hematologic cancer	8.25e-05	0.000304	CcSEcCtD
Cyproheptadine—Shock—Dexamethasone—hematologic cancer	8.25e-05	0.000304	CcSEcCtD
Cyproheptadine—Rash—Alitretinoin—hematologic cancer	8.23e-05	0.000303	CcSEcCtD
Cyproheptadine—Agitation—Prednisone—hematologic cancer	8.22e-05	0.000303	CcSEcCtD
Cyproheptadine—Dermatitis—Alitretinoin—hematologic cancer	8.22e-05	0.000303	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Dexamethasone—hematologic cancer	8.21e-05	0.000302	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Betamethasone—hematologic cancer	8.21e-05	0.000302	CcSEcCtD
Cyproheptadine—Vomiting—Ifosfamide—hematologic cancer	8.2e-05	0.000302	CcSEcCtD
Cyproheptadine—Tachycardia—Betamethasone—hematologic cancer	8.19e-05	0.000301	CcSEcCtD
Cyproheptadine—Tachycardia—Dexamethasone—hematologic cancer	8.19e-05	0.000301	CcSEcCtD
Cyproheptadine—Headache—Alitretinoin—hematologic cancer	8.18e-05	0.000301	CcSEcCtD
Cyproheptadine—Diarrhoea—Gemcitabine—hematologic cancer	8.17e-05	0.0003	CcSEcCtD
Cyproheptadine—Nausea—Thalidomide—hematologic cancer	8.15e-05	0.0003	CcSEcCtD
Cyproheptadine—Dyspepsia—Triamcinolone—hematologic cancer	8.14e-05	0.000299	CcSEcCtD
Cyproheptadine—Rash—Ifosfamide—hematologic cancer	8.14e-05	0.000299	CcSEcCtD
Cyproheptadine—Dermatitis—Ifosfamide—hematologic cancer	8.13e-05	0.000299	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—hematologic cancer	8.12e-05	0.000299	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Dexamethasone—hematologic cancer	8.11e-05	0.000298	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Betamethasone—hematologic cancer	8.11e-05	0.000298	CcSEcCtD
Cyproheptadine—Dizziness—Irinotecan—hematologic cancer	8.1e-05	0.000298	CcSEcCtD
Cyproheptadine—Urticaria—Etoposide—hematologic cancer	8.1e-05	0.000298	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—hematologic cancer	8.08e-05	0.000297	CcSEcCtD
Cyproheptadine—Vertigo—Prednisone—hematologic cancer	8.04e-05	0.000296	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—hematologic cancer	8.04e-05	0.000296	CcSEcCtD
Cyproheptadine—Syncope—Prednisone—hematologic cancer	8.03e-05	0.000295	CcSEcCtD
Cyproheptadine—Tinnitus—Methotrexate—hematologic cancer	8.01e-05	0.000295	CcSEcCtD
Cyproheptadine—Vomiting—Vincristine—hematologic cancer	8e-05	0.000294	CcSEcCtD
Cyproheptadine—Anorexia—Dexamethasone—hematologic cancer	7.99e-05	0.000294	CcSEcCtD
Cyproheptadine—Anorexia—Betamethasone—hematologic cancer	7.99e-05	0.000294	CcSEcCtD
Cyproheptadine—Urticaria—Prednisolone—hematologic cancer	7.98e-05	0.000294	CcSEcCtD
Cyproheptadine—Asthenia—Cisplatin—hematologic cancer	7.98e-05	0.000294	CcSEcCtD
Cyproheptadine—Fatigue—Triamcinolone—hematologic cancer	7.97e-05	0.000293	CcSEcCtD
Cyproheptadine—Rash—Vincristine—hematologic cancer	7.93e-05	0.000292	CcSEcCtD
Cyproheptadine—Dermatitis—Vincristine—hematologic cancer	7.92e-05	0.000292	CcSEcCtD
Cyproheptadine—Headache—Vincristine—hematologic cancer	7.88e-05	0.00029	CcSEcCtD
Cyproheptadine—Carbamazepine—ABCB1—hematologic cancer	7.87e-05	0.0451	CrCbGaD
Cyproheptadine—Loss of consciousness—Prednisone—hematologic cancer	7.87e-05	0.000289	CcSEcCtD
Cyproheptadine—Hypotension—Dexamethasone—hematologic cancer	7.84e-05	0.000288	CcSEcCtD
Cyproheptadine—Hypotension—Betamethasone—hematologic cancer	7.84e-05	0.000288	CcSEcCtD
Cyproheptadine—Nausea—Carmustine—hematologic cancer	7.83e-05	0.000288	CcSEcCtD
Cyproheptadine—Vomiting—Irinotecan—hematologic cancer	7.79e-05	0.000287	CcSEcCtD
Cyproheptadine—Vomiting—Mitoxantrone—hematologic cancer	7.79e-05	0.000287	CcSEcCtD
Cyproheptadine—Nausea—Alitretinoin—hematologic cancer	7.75e-05	0.000285	CcSEcCtD
Cyproheptadine—Convulsion—Prednisone—hematologic cancer	7.75e-05	0.000285	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—hematologic cancer	7.73e-05	0.000285	CcSEcCtD
Cyproheptadine—Rash—Mitoxantrone—hematologic cancer	7.72e-05	0.000284	CcSEcCtD
Cyproheptadine—Rash—Irinotecan—hematologic cancer	7.72e-05	0.000284	CcSEcCtD
Cyproheptadine—Dermatitis—Mitoxantrone—hematologic cancer	7.72e-05	0.000284	CcSEcCtD
Cyproheptadine—Dermatitis—Irinotecan—hematologic cancer	7.72e-05	0.000284	CcSEcCtD
Cyproheptadine—Chills—Methotrexate—hematologic cancer	7.71e-05	0.000284	CcSEcCtD
Cyproheptadine—Headache—Mitoxantrone—hematologic cancer	7.67e-05	0.000282	CcSEcCtD
Cyproheptadine—Headache—Irinotecan—hematologic cancer	7.67e-05	0.000282	CcSEcCtD
Cyproheptadine—Nausea—Ifosfamide—hematologic cancer	7.66e-05	0.000282	CcSEcCtD
Cyproheptadine—Feeling abnormal—Triamcinolone—hematologic cancer	7.62e-05	0.00028	CcSEcCtD
Cyproheptadine—Diarrhoea—Cisplatin—hematologic cancer	7.61e-05	0.00028	CcSEcCtD
Cyproheptadine—Vomiting—Gemcitabine—hematologic cancer	7.59e-05	0.000279	CcSEcCtD
Cyproheptadine—Insomnia—Betamethasone—hematologic cancer	7.59e-05	0.000279	CcSEcCtD
Cyproheptadine—Insomnia—Dexamethasone—hematologic cancer	7.59e-05	0.000279	CcSEcCtD
Cyproheptadine—Paraesthesia—Dexamethasone—hematologic cancer	7.53e-05	0.000277	CcSEcCtD
Cyproheptadine—Paraesthesia—Betamethasone—hematologic cancer	7.53e-05	0.000277	CcSEcCtD
Cyproheptadine—Rash—Gemcitabine—hematologic cancer	7.52e-05	0.000277	CcSEcCtD
Cyproheptadine—Dermatitis—Gemcitabine—hematologic cancer	7.52e-05	0.000277	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—hematologic cancer	7.5e-05	0.000276	CcSEcCtD
Cyproheptadine—Headache—Gemcitabine—hematologic cancer	7.48e-05	0.000275	CcSEcCtD
Cyproheptadine—Nausea—Vincristine—hematologic cancer	7.47e-05	0.000275	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—hematologic cancer	7.44e-05	0.000274	CcSEcCtD
Cyproheptadine—Dyspepsia—Dexamethasone—hematologic cancer	7.38e-05	0.000272	CcSEcCtD
Cyproheptadine—Dyspepsia—Betamethasone—hematologic cancer	7.38e-05	0.000272	CcSEcCtD
Cyproheptadine—Urticaria—Triamcinolone—hematologic cancer	7.34e-05	0.00027	CcSEcCtD
Cyproheptadine—Asthenia—Etoposide—hematologic cancer	7.31e-05	0.000269	CcSEcCtD
Cyproheptadine—Oedema—Prednisone—hematologic cancer	7.3e-05	0.000269	CcSEcCtD
Cyproheptadine—Decreased appetite—Dexamethasone—hematologic cancer	7.29e-05	0.000268	CcSEcCtD
Cyproheptadine—Decreased appetite—Betamethasone—hematologic cancer	7.29e-05	0.000268	CcSEcCtD
Cyproheptadine—Nausea—Mitoxantrone—hematologic cancer	7.28e-05	0.000268	CcSEcCtD
Cyproheptadine—Nausea—Irinotecan—hematologic cancer	7.28e-05	0.000268	CcSEcCtD
Cyproheptadine—Fatigue—Dexamethasone—hematologic cancer	7.23e-05	0.000266	CcSEcCtD
Cyproheptadine—Fatigue—Betamethasone—hematologic cancer	7.23e-05	0.000266	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—hematologic cancer	7.21e-05	0.000265	CcSEcCtD
Cyproheptadine—Shock—Prednisone—hematologic cancer	7.19e-05	0.000264	CcSEcCtD
Cyproheptadine—Tachycardia—Prednisone—hematologic cancer	7.13e-05	0.000262	CcSEcCtD
Cyproheptadine—Nausea—Gemcitabine—hematologic cancer	7.09e-05	0.000261	CcSEcCtD
Cyproheptadine—Vomiting—Cisplatin—hematologic cancer	7.07e-05	0.00026	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Prednisone—hematologic cancer	7.06e-05	0.00026	CcSEcCtD
Cyproheptadine—Vision blurred—Methotrexate—hematologic cancer	7.05e-05	0.000259	CcSEcCtD
Cyproheptadine—Rash—Cisplatin—hematologic cancer	7.01e-05	0.000258	CcSEcCtD
Cyproheptadine—Dermatitis—Cisplatin—hematologic cancer	7.01e-05	0.000258	CcSEcCtD
Cyproheptadine—Diarrhoea—Etoposide—hematologic cancer	6.97e-05	0.000257	CcSEcCtD
Cyproheptadine—Anorexia—Prednisone—hematologic cancer	6.96e-05	0.000256	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—hematologic cancer	6.94e-05	0.000255	CcSEcCtD
Cyproheptadine—Feeling abnormal—Dexamethasone—hematologic cancer	6.91e-05	0.000254	CcSEcCtD
Cyproheptadine—Feeling abnormal—Betamethasone—hematologic cancer	6.91e-05	0.000254	CcSEcCtD
Cyproheptadine—Tension—Epirubicin—hematologic cancer	6.87e-05	0.000253	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—hematologic cancer	6.8e-05	0.00025	CcSEcCtD
Cyproheptadine—Nortriptyline—ALB—hematologic cancer	6.79e-05	0.0389	CrCbGaD
Cyproheptadine—Dizziness—Etoposide—hematologic cancer	6.74e-05	0.000248	CcSEcCtD
Cyproheptadine—Vertigo—Methotrexate—hematologic cancer	6.72e-05	0.000247	CcSEcCtD
Cyproheptadine—Leukopenia—Methotrexate—hematologic cancer	6.69e-05	0.000246	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—hematologic cancer	6.68e-05	0.000246	CcSEcCtD
Cyproheptadine—Urticaria—Dexamethasone—hematologic cancer	6.66e-05	0.000245	CcSEcCtD
Cyproheptadine—Urticaria—Betamethasone—hematologic cancer	6.66e-05	0.000245	CcSEcCtD
Cyproheptadine—Dizziness—Prednisolone—hematologic cancer	6.65e-05	0.000245	CcSEcCtD
Cyproheptadine—Asthenia—Triamcinolone—hematologic cancer	6.63e-05	0.000244	CcSEcCtD
Cyproheptadine—Nausea—Cisplatin—hematologic cancer	6.61e-05	0.000243	CcSEcCtD
Cyproheptadine—Insomnia—Prednisone—hematologic cancer	6.61e-05	0.000243	CcSEcCtD
Cyproheptadine—Vision blurred—Epirubicin—hematologic cancer	6.6e-05	0.000243	CcSEcCtD
Cyproheptadine—Paraesthesia—Prednisone—hematologic cancer	6.56e-05	0.000241	CcSEcCtD
Cyproheptadine—Convulsion—Methotrexate—hematologic cancer	6.48e-05	0.000238	CcSEcCtD
Cyproheptadine—Vomiting—Etoposide—hematologic cancer	6.48e-05	0.000238	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—hematologic cancer	6.43e-05	0.000237	CcSEcCtD
Cyproheptadine—Dyspepsia—Prednisone—hematologic cancer	6.43e-05	0.000237	CcSEcCtD
Cyproheptadine—Rash—Etoposide—hematologic cancer	6.43e-05	0.000236	CcSEcCtD
Cyproheptadine—Dermatitis—Etoposide—hematologic cancer	6.42e-05	0.000236	CcSEcCtD
Cyproheptadine—Headache—Etoposide—hematologic cancer	6.38e-05	0.000235	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—hematologic cancer	6.35e-05	0.000234	CcSEcCtD
Cyproheptadine—Decreased appetite—Prednisone—hematologic cancer	6.35e-05	0.000234	CcSEcCtD
Cyproheptadine—Rash—Prednisolone—hematologic cancer	6.34e-05	0.000233	CcSEcCtD
Cyproheptadine—Dermatitis—Prednisolone—hematologic cancer	6.33e-05	0.000233	CcSEcCtD
Cyproheptadine—Fatigue—Prednisone—hematologic cancer	6.3e-05	0.000232	CcSEcCtD
Cyproheptadine—Headache—Prednisolone—hematologic cancer	6.3e-05	0.000232	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—hematologic cancer	6.29e-05	0.000231	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—hematologic cancer	6.29e-05	0.000231	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—hematologic cancer	6.28e-05	0.000231	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—hematologic cancer	6.27e-05	0.000231	CcSEcCtD
Cyproheptadine—Constipation—Prednisone—hematologic cancer	6.25e-05	0.00023	CcSEcCtD
Cyproheptadine—Palpitations—Epirubicin—hematologic cancer	6.19e-05	0.000228	CcSEcCtD
Cyproheptadine—Confusional state—Methotrexate—hematologic cancer	6.15e-05	0.000226	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—hematologic cancer	6.15e-05	0.000226	CcSEcCtD
Cyproheptadine—Dizziness—Triamcinolone—hematologic cancer	6.11e-05	0.000225	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—hematologic cancer	6.1e-05	0.000225	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—hematologic cancer	6.06e-05	0.000223	CcSEcCtD
Cyproheptadine—Nausea—Etoposide—hematologic cancer	6.05e-05	0.000223	CcSEcCtD
Cyproheptadine—Feeling abnormal—Prednisone—hematologic cancer	6.02e-05	0.000221	CcSEcCtD
Cyproheptadine—Asthenia—Dexamethasone—hematologic cancer	6.02e-05	0.000221	CcSEcCtD
Cyproheptadine—Asthenia—Betamethasone—hematologic cancer	6.02e-05	0.000221	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Methotrexate—hematologic cancer	5.98e-05	0.00022	CcSEcCtD
Cyproheptadine—Nausea—Prednisolone—hematologic cancer	5.97e-05	0.00022	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—hematologic cancer	5.95e-05	0.000219	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methotrexate—hematologic cancer	5.9e-05	0.000217	CcSEcCtD
Cyproheptadine—Vomiting—Triamcinolone—hematologic cancer	5.88e-05	0.000216	CcSEcCtD
Cyproheptadine—Rash—Triamcinolone—hematologic cancer	5.83e-05	0.000214	CcSEcCtD
Cyproheptadine—Dermatitis—Triamcinolone—hematologic cancer	5.82e-05	0.000214	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—hematologic cancer	5.82e-05	0.000214	CcSEcCtD
Cyproheptadine—Anorexia—Methotrexate—hematologic cancer	5.82e-05	0.000214	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—hematologic cancer	5.81e-05	0.000214	CcSEcCtD
Cyproheptadine—Urticaria—Prednisone—hematologic cancer	5.8e-05	0.000214	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—hematologic cancer	5.8e-05	0.000213	CcSEcCtD
Cyproheptadine—Headache—Triamcinolone—hematologic cancer	5.79e-05	0.000213	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—hematologic cancer	5.76e-05	0.000212	CcSEcCtD
Cyproheptadine—Diarrhoea—Dexamethasone—hematologic cancer	5.74e-05	0.000211	CcSEcCtD
Cyproheptadine—Diarrhoea—Betamethasone—hematologic cancer	5.74e-05	0.000211	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—hematologic cancer	5.72e-05	0.000211	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—hematologic cancer	5.71e-05	0.00021	CcSEcCtD
Cyproheptadine—Hypotension—Methotrexate—hematologic cancer	5.7e-05	0.00021	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—hematologic cancer	5.69e-05	0.000209	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—hematologic cancer	5.62e-05	0.000207	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—hematologic cancer	5.61e-05	0.000206	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—hematologic cancer	5.59e-05	0.000206	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—hematologic cancer	5.57e-05	0.000205	CcSEcCtD
Cyproheptadine—Dizziness—Dexamethasone—hematologic cancer	5.55e-05	0.000204	CcSEcCtD
Cyproheptadine—Dizziness—Betamethasone—hematologic cancer	5.55e-05	0.000204	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Epirubicin—hematologic cancer	5.52e-05	0.000203	CcSEcCtD
Cyproheptadine—Insomnia—Methotrexate—hematologic cancer	5.52e-05	0.000203	CcSEcCtD
Cyproheptadine—Nausea—Triamcinolone—hematologic cancer	5.49e-05	0.000202	CcSEcCtD
Cyproheptadine—Paraesthesia—Methotrexate—hematologic cancer	5.48e-05	0.000202	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—hematologic cancer	5.44e-05	0.0002	CcSEcCtD
Cyproheptadine—Somnolence—Methotrexate—hematologic cancer	5.43e-05	0.0002	CcSEcCtD
Cyproheptadine—Dyspepsia—Methotrexate—hematologic cancer	5.37e-05	0.000198	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—hematologic cancer	5.34e-05	0.000196	CcSEcCtD
Cyproheptadine—Vomiting—Dexamethasone—hematologic cancer	5.33e-05	0.000196	CcSEcCtD
Cyproheptadine—Vomiting—Betamethasone—hematologic cancer	5.33e-05	0.000196	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—hematologic cancer	5.33e-05	0.000196	CcSEcCtD
Cyproheptadine—Decreased appetite—Methotrexate—hematologic cancer	5.31e-05	0.000195	CcSEcCtD
Cyproheptadine—Rash—Betamethasone—hematologic cancer	5.29e-05	0.000195	CcSEcCtD
Cyproheptadine—Rash—Dexamethasone—hematologic cancer	5.29e-05	0.000195	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—hematologic cancer	5.29e-05	0.000194	CcSEcCtD
Cyproheptadine—Dermatitis—Betamethasone—hematologic cancer	5.28e-05	0.000194	CcSEcCtD
Cyproheptadine—Dermatitis—Dexamethasone—hematologic cancer	5.28e-05	0.000194	CcSEcCtD
Cyproheptadine—Fatigue—Methotrexate—hematologic cancer	5.26e-05	0.000194	CcSEcCtD
Cyproheptadine—Headache—Dexamethasone—hematologic cancer	5.25e-05	0.000193	CcSEcCtD
Cyproheptadine—Headache—Betamethasone—hematologic cancer	5.25e-05	0.000193	CcSEcCtD
Cyproheptadine—Asthenia—Prednisone—hematologic cancer	5.24e-05	0.000193	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—hematologic cancer	5.2e-05	0.000191	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—hematologic cancer	5.17e-05	0.00019	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—hematologic cancer	5.17e-05	0.00019	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—hematologic cancer	5.16e-05	0.00019	CcSEcCtD
Cyproheptadine—Paraesthesia—Epirubicin—hematologic cancer	5.13e-05	0.000189	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—hematologic cancer	5.11e-05	0.000188	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—hematologic cancer	5.08e-05	0.000187	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—hematologic cancer	5.04e-05	0.000185	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methotrexate—hematologic cancer	5.03e-05	0.000185	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—hematologic cancer	5.03e-05	0.000185	CcSEcCtD
Cyproheptadine—Diarrhoea—Prednisone—hematologic cancer	5e-05	0.000184	CcSEcCtD
Cyproheptadine—Nausea—Dexamethasone—hematologic cancer	4.98e-05	0.000183	CcSEcCtD
Cyproheptadine—Nausea—Betamethasone—hematologic cancer	4.98e-05	0.000183	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—hematologic cancer	4.97e-05	0.000183	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—hematologic cancer	4.94e-05	0.000182	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—hematologic cancer	4.92e-05	0.000181	CcSEcCtD
Cyproheptadine—Constipation—Epirubicin—hematologic cancer	4.88e-05	0.00018	CcSEcCtD
Cyproheptadine—Urticaria—Methotrexate—hematologic cancer	4.85e-05	0.000178	CcSEcCtD
Cyproheptadine—Clozapine—ABCB1—hematologic cancer	4.84e-05	0.0277	CrCbGaD
Cyproheptadine—Dizziness—Prednisone—hematologic cancer	4.83e-05	0.000178	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—hematologic cancer	4.78e-05	0.000176	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—hematologic cancer	4.75e-05	0.000175	CcSEcCtD
Cyproheptadine—Amitriptyline—ALB—hematologic cancer	4.71e-05	0.027	CrCbGaD
Cyproheptadine—Feeling abnormal—Epirubicin—hematologic cancer	4.71e-05	0.000173	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—hematologic cancer	4.7e-05	0.000173	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—hematologic cancer	4.65e-05	0.000171	CcSEcCtD
Cyproheptadine—Vomiting—Prednisone—hematologic cancer	4.64e-05	0.000171	CcSEcCtD
Cyproheptadine—Rash—Prednisone—hematologic cancer	4.61e-05	0.000169	CcSEcCtD
Cyproheptadine—Dermatitis—Prednisone—hematologic cancer	4.6e-05	0.000169	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—hematologic cancer	4.59e-05	0.000169	CcSEcCtD
Cyproheptadine—Headache—Prednisone—hematologic cancer	4.58e-05	0.000168	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—hematologic cancer	4.56e-05	0.000168	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—hematologic cancer	4.54e-05	0.000167	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—hematologic cancer	4.52e-05	0.000166	CcSEcCtD
Cyproheptadine—Amitriptyline—ABCB1—hematologic cancer	4.5e-05	0.0258	CrCbGaD
Cyproheptadine—Asthenia—Methotrexate—hematologic cancer	4.38e-05	0.000161	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—hematologic cancer	4.36e-05	0.00016	CcSEcCtD
Cyproheptadine—Nausea—Prednisone—hematologic cancer	4.34e-05	0.00016	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—hematologic cancer	4.2e-05	0.000155	CcSEcCtD
Cyproheptadine—Diarrhoea—Methotrexate—hematologic cancer	4.18e-05	0.000154	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—hematologic cancer	4.1e-05	0.000151	CcSEcCtD
Cyproheptadine—Dizziness—Methotrexate—hematologic cancer	4.04e-05	0.000149	CcSEcCtD
Cyproheptadine—Diarrhoea—Epirubicin—hematologic cancer	3.91e-05	0.000144	CcSEcCtD
Cyproheptadine—Vomiting—Methotrexate—hematologic cancer	3.88e-05	0.000143	CcSEcCtD
Cyproheptadine—Rash—Methotrexate—hematologic cancer	3.85e-05	0.000142	CcSEcCtD
Cyproheptadine—Dermatitis—Methotrexate—hematologic cancer	3.85e-05	0.000141	CcSEcCtD
Cyproheptadine—Headache—Methotrexate—hematologic cancer	3.82e-05	0.000141	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—hematologic cancer	3.79e-05	0.00014	CcSEcCtD
Cyproheptadine—Dizziness—Epirubicin—hematologic cancer	3.78e-05	0.000139	CcSEcCtD
Cyproheptadine—Vomiting—Epirubicin—hematologic cancer	3.63e-05	0.000134	CcSEcCtD
Cyproheptadine—Nausea—Methotrexate—hematologic cancer	3.63e-05	0.000133	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—hematologic cancer	3.62e-05	0.000133	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—hematologic cancer	3.6e-05	0.000133	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—hematologic cancer	3.6e-05	0.000132	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—hematologic cancer	3.58e-05	0.000132	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—hematologic cancer	3.5e-05	0.000129	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—hematologic cancer	3.39e-05	0.000125	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—hematologic cancer	3.36e-05	0.000124	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—hematologic cancer	3.33e-05	0.000123	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—hematologic cancer	3.33e-05	0.000123	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—hematologic cancer	3.31e-05	0.000122	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—hematologic cancer	3.14e-05	0.000116	CcSEcCtD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	3.76e-06	3.68e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL2—hematologic cancer	3.76e-06	3.68e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CASP3—hematologic cancer	3.75e-06	3.67e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—hematologic cancer	3.74e-06	3.66e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL2—hematologic cancer	3.74e-06	3.66e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK3—hematologic cancer	3.73e-06	3.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—JAK2—hematologic cancer	3.72e-06	3.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—hematologic cancer	3.72e-06	3.64e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—JAK2—hematologic cancer	3.72e-06	3.64e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	3.71e-06	3.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—JAK2—hematologic cancer	3.7e-06	3.63e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MDM2—hematologic cancer	3.69e-06	3.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—JAK2—hematologic cancer	3.69e-06	3.61e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—KRAS—hematologic cancer	3.67e-06	3.59e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCND1—hematologic cancer	3.66e-06	3.59e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—JUN—hematologic cancer	3.66e-06	3.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	3.66e-06	3.58e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	3.65e-06	3.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCND1—hematologic cancer	3.65e-06	3.57e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	3.64e-06	3.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—JUN—hematologic cancer	3.64e-06	3.56e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MDM2—hematologic cancer	3.63e-06	3.56e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	3.63e-06	3.55e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MDM2—hematologic cancer	3.63e-06	3.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—hematologic cancer	3.62e-06	3.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTEN—hematologic cancer	3.62e-06	3.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	3.62e-06	3.54e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—hematologic cancer	3.62e-06	3.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MDM2—hematologic cancer	3.61e-06	3.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MDM2—hematologic cancer	3.6e-06	3.53e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	3.59e-06	3.52e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MTOR—hematologic cancer	3.59e-06	3.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	3.58e-06	3.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	3.57e-06	3.49e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	3.54e-06	3.47e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PTEN—hematologic cancer	3.54e-06	3.46e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MTOR—hematologic cancer	3.54e-06	3.46e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	3.54e-06	3.46e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MTOR—hematologic cancer	3.53e-06	3.46e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	3.53e-06	3.46e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CDKN1A—hematologic cancer	3.53e-06	3.45e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTEN—hematologic cancer	3.52e-06	3.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MTOR—hematologic cancer	3.52e-06	3.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	3.52e-06	3.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MTOR—hematologic cancer	3.51e-06	3.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	3.51e-06	3.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	3.47e-06	3.4e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	3.47e-06	3.4e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	3.46e-06	3.39e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—EP300—hematologic cancer	3.46e-06	3.38e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	3.45e-06	3.38e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK8—hematologic cancer	3.44e-06	3.37e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—hematologic cancer	3.43e-06	3.36e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HRAS—hematologic cancer	3.43e-06	3.36e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	3.38e-06	3.31e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EP300—hematologic cancer	3.37e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	3.37e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—hematologic cancer	3.37e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	3.37e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	3.36e-06	3.29e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EP300—hematologic cancer	3.36e-06	3.29e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KRAS—hematologic cancer	3.35e-06	3.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	3.35e-06	3.28e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	3.34e-06	3.27e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	3.32e-06	3.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	3.31e-06	3.25e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	3.31e-06	3.24e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—hematologic cancer	3.31e-06	3.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	3.3e-06	3.23e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—hematologic cancer	3.3e-06	3.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	3.29e-06	3.22e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—hematologic cancer	3.28e-06	3.22e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	3.28e-06	3.21e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SRC—hematologic cancer	3.28e-06	3.21e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	3.28e-06	3.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	3.27e-06	3.2e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SRC—hematologic cancer	3.26e-06	3.2e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—hematologic cancer	3.26e-06	3.19e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	3.26e-06	3.19e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	3.25e-06	3.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—hematologic cancer	3.25e-06	3.18e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—hematologic cancer	3.25e-06	3.18e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—hematologic cancer	3.25e-06	3.18e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—hematologic cancer	3.24e-06	3.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—hematologic cancer	3.23e-06	3.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—hematologic cancer	3.23e-06	3.16e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—hematologic cancer	3.23e-06	3.16e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—hematologic cancer	3.22e-06	3.16e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—hematologic cancer	3.22e-06	3.16e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	3.22e-06	3.16e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—hematologic cancer	3.22e-06	3.15e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCND1—hematologic cancer	3.22e-06	3.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	3.21e-06	3.15e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—JUN—hematologic cancer	3.21e-06	3.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—hematologic cancer	3.2e-06	3.14e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	3.19e-06	3.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	3.19e-06	3.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—hematologic cancer	3.19e-06	3.12e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	3.18e-06	3.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	3.17e-06	3.11e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCND1—hematologic cancer	3.17e-06	3.1e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	3.16e-06	3.1e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—JUN—hematologic cancer	3.16e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCND1—hematologic cancer	3.16e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	3.16e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—JUN—hematologic cancer	3.15e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	3.15e-06	3.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—hematologic cancer	3.15e-06	3.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—JUN—hematologic cancer	3.14e-06	3.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NRAS—hematologic cancer	3.14e-06	3.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCND1—hematologic cancer	3.14e-06	3.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—JUN—hematologic cancer	3.13e-06	3.07e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HRAS—hematologic cancer	3.12e-06	3.05e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	3.11e-06	3.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	3.11e-06	3.04e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTEN—hematologic cancer	3.11e-06	3.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—JUN—hematologic cancer	3.1e-06	3.04e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—hematologic cancer	3.08e-06	3.01e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	3.06e-06	3e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	3.06e-06	2.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTEN—hematologic cancer	3.06e-06	2.99e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTEN—hematologic cancer	3.05e-06	2.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	3.05e-06	2.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	3.04e-06	2.98e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	3.04e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	3.04e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	3.03e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTEN—hematologic cancer	3.03e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	3.02e-06	2.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	3.01e-06	2.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	3.01e-06	2.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	3e-06	2.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	2.99e-06	2.93e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—hematologic cancer	2.98e-06	2.92e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	2.98e-06	2.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	2.98e-06	2.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—hematologic cancer	2.98e-06	2.91e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	2.97e-06	2.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	2.97e-06	2.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	2.96e-06	2.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	2.96e-06	2.9e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EP300—hematologic cancer	2.96e-06	2.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	2.96e-06	2.89e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—hematologic cancer	2.94e-06	2.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	2.93e-06	2.87e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	2.93e-06	2.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	2.93e-06	2.87e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—hematologic cancer	2.92e-06	2.86e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	2.92e-06	2.86e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EP300—hematologic cancer	2.91e-06	2.85e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EP300—hematologic cancer	2.91e-06	2.85e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EP300—hematologic cancer	2.9e-06	2.84e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EP300—hematologic cancer	2.89e-06	2.83e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SRC—hematologic cancer	2.88e-06	2.82e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EP300—hematologic cancer	2.86e-06	2.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HRAS—hematologic cancer	2.85e-06	2.79e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SRC—hematologic cancer	2.83e-06	2.77e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SRC—hematologic cancer	2.83e-06	2.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SRC—hematologic cancer	2.82e-06	2.76e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SRC—hematologic cancer	2.81e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	2.8e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SRC—hematologic cancer	2.78e-06	2.72e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—hematologic cancer	2.78e-06	2.72e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NRAS—hematologic cancer	2.77e-06	2.71e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	2.76e-06	2.7e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	2.75e-06	2.7e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—hematologic cancer	2.75e-06	2.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	2.75e-06	2.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	2.74e-06	2.68e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	2.73e-06	2.68e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—hematologic cancer	2.73e-06	2.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	2.73e-06	2.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—hematologic cancer	2.72e-06	2.67e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NRAS—hematologic cancer	2.72e-06	2.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	2.72e-06	2.66e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	2.72e-06	2.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	2.71e-06	2.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	2.71e-06	2.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	2.71e-06	2.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	2.7e-06	2.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	2.7e-06	2.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	2.68e-06	2.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	2.68e-06	2.62e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	2.65e-06	2.6e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	2.61e-06	2.56e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	2.61e-06	2.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	2.6e-06	2.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	2.59e-06	2.53e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—hematologic cancer	2.58e-06	2.53e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	2.57e-06	2.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	2.56e-06	2.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—hematologic cancer	2.56e-06	2.5e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—hematologic cancer	2.54e-06	2.49e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—hematologic cancer	2.53e-06	2.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	2.53e-06	2.48e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	2.53e-06	2.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—hematologic cancer	2.53e-06	2.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	2.52e-06	2.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—hematologic cancer	2.52e-06	2.47e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—hematologic cancer	2.51e-06	2.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	2.51e-06	2.46e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	2.5e-06	2.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—hematologic cancer	2.49e-06	2.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	2.49e-06	2.44e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	2.48e-06	2.43e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—hematologic cancer	2.41e-06	2.36e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—hematologic cancer	2.4e-06	2.35e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KRAS—hematologic cancer	2.38e-06	2.34e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	2.35e-06	2.3e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KRAS—hematologic cancer	2.34e-06	2.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	2.33e-06	2.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	2.33e-06	2.28e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	2.31e-06	2.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	2.3e-06	2.26e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	2.3e-06	2.25e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—hematologic cancer	2.21e-06	2.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—hematologic cancer	2.2e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	2.19e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	2.16e-06	2.11e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	2.15e-06	2.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.14e-06	2.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	2.14e-06	2.09e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—hematologic cancer	2.12e-06	2.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	2.12e-06	2.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—hematologic cancer	2.09e-06	2.04e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—hematologic cancer	2.09e-06	2.04e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—hematologic cancer	2.08e-06	2.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—hematologic cancer	2.07e-06	2.03e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—hematologic cancer	2.07e-06	2.02e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—hematologic cancer	2.05e-06	2.01e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	2.04e-06	2e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	2.03e-06	1.99e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HRAS—hematologic cancer	2.03e-06	1.98e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.99e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.99e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	1.98e-06	1.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	1.98e-06	1.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	1.96e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—hematologic cancer	1.94e-06	1.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—hematologic cancer	1.91e-06	1.87e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.9e-06	1.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—hematologic cancer	1.9e-06	1.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—hematologic cancer	1.89e-06	1.85e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—hematologic cancer	1.87e-06	1.84e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.79e-06	1.75e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.76e-06	1.72e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.76e-06	1.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	1.75e-06	1.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	1.75e-06	1.71e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1.73e-06	1.69e-05	CbGpPWpGaD
